Researchers from ESPCI Paris and the Institut de Recherche Criminelle de la Gendarmerie Nationale have developed and optimized a comprehensive two-dimensional GC–MS method for the forensic profiling of human hand odour.
Photo Credit: lantapix/Shutterstock.com
Researchers from ESPCI Paris and the Institut de Recherche Criminelle de la Gendarmerie Nationale have developed and optimized a comprehensive two-dimensional gas chromatography–mass spectrometry (GC–MS) method for the forensic profiling of human hand odour (1).
Like fingerprints, human odour is said to be specific to each individual, consisting of hundreds of molecules, and has long played a role in crime investigation through the highly trained and unscrupulous nose of police dogs. However, during court proceedings more conclusive evidence is required and thus the development of an objective analytical strategy to characterize human odour is needed to complement existing canine capabilities.
The complexity of human odour is one of the major challenges to the development of such a technique, with comprehensive reviews of human-originating volatiles finding a wide variety of chemical compounds, including: acids, alcohols, aldehydes, esters, hydrocarbons, ketones, heterocyclic compounds, and sulphur-containing compounds (2,3).
Researchers reasoned that GC–MS would be the most appropriate method because of the nature of the molecules involved, but based upon the sample complexity and the peak capacity limitations of classic one-dimensional GC–MS it was determined that GC×GC–MS would be better suited. In order to optimize the method, 27 different analytical setups were evaluated based upon the criteria of column set, gradient, and a modulation time.
Results indicated that based upon the analytical criteria, including six complementary orthogonality criteria, the developed method was appropriate for the analysis of human hand odour.
References
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.